Gastro-intestinal system
Cardiovascular system
- CV1 Guideline for the Use of Anticoagulants in Atrial Fibrillation
- AHSN guide to Anticoagulants in Atrial Fibrillation
- CV2 Guideline for Lipid Modification Treatment (SLiMS)
- SLiMS supplement – PCSK9 inhibitors
Respiratory system
- RS1 Guideline for the Treatment of Asthma in Adults
- RS2 Guideline for the Choice of Inhalers in Asthma
- RS3 Guideline for the Treatment of COPD
- RS4 Guideline for the Choice of Inhalers for COPD
- RS5 Guideline for the Switching of Inhalers in COPD
- RS6 Guideline for Reducing ICS (Inhaled Corticosteroids) in COPD Patients
Central nervous system
- CNS1 Guideline for the Treatment of Headache and Migraine
- CNS2 SCCG Position Statement: Nefopam
- CNS3 Guideline for the Treatment of Nociceptive and Neuropathic Pain
- CNS4 Quick Reference Guide: Treatment of Nociceptive and Neuropathic Pain
- CNS5 Guideline for Reducing and Stopping Treatment with Dosulepin
- CNS6 Medical cannabis: advice for clinicians
- CNS7 Medical cannabis: advice for patients
Infection
- INF1 NICE antimicrobial prescribing guidance *BASED ON LOCAL DATA CEFALEXIN IS FIRST LINE FOR URINARY TRACT INFECTION IN CHILDREN*
- INF2 Quick Reference Guide Antibiotic Prescribing in Adults and Children
- INF3 Risk Assessment for Clostridium difficile infection
- INF4 Guideline for Relapsing or Recurrent UTI (taken from CHS)
Endocrine system
- Flash Glucose Monitoring System (FreeStyle Libre): North East and North Cumbria Joint Committee Position Statement, May 2019
- END1 Guideline for the Treatment of Type2 Diabetes in Adults
- END2 Guidance on the Self-Monitoring of Blood Glucose in Adults with Type 2 Diabetes
- Sunderland Diabetes Network: Safe Prescribing of Insulin – for General Practice
- Sunderland Diabetes Network: Safe Dispensing of Insulin – for Community Pharmacy
- Information for patients: Dapagliflozin, canagliflozin and empagliflozin (SGLT2 inhibitors) for Type 2 Diabetes
- END3 Guideline for use of Gender Dysphoria Feminising Hormones
- END4 Guideline for the use of Gender Dysphoria Masculinising Hormones
- END5 Guideline for the Treatment of Osteoporosis
Immune system and malignant disease
- Quick Guide: LHRA Analogues for the Treatment of Prostate Cancer
- Quick Guide: LHRA Analogues for the Treatment of Prostate Cancer (grouped by administration interval)
Blood and nutrition
- NUT1 Guideline for the initiationof Oral Nutritional Supplements ONS in Adults
- NUT2 Guideline for the prescribing of Oral Nutritional Supplements ONS in Adults
- NUT3 Quick Guide ONS
- Information for Patients: Eating with a Small Appetite NHS Booklet
- NUT4 Guideline for the Prescribing of Infant Formula for Infants with suspected Cow’s Milk Protein Allergy (CMPA) or Lactose Intolerance
- NUT5 Guideline for Gluten free Prescribing v2.0
Eye
Skin
- SKIN1 Guideline for the Prescribing of Emollients
- Patient Information Leaflet: Emollient Information
- SKIN2 Wound Product Formulary (adopted from CHS and South Tyneside Foundation Trust)
Appliances
- APP1 Guideline for the Prescribing of Stoma Products
- Stoma Care Nursing Service Referral Form: SAD35
- APP2 Guideline for the Prescribing of Rectal Irrigation
Miscellaneous
- MISC1 Sunderland DROP list
- MISC2 Repeat Dispensing Reference Guide
- MISC3 Repeat Dispensing Guide to Mid-Batch Script Changes
- MISC4 Guidelines the Red/ Amber/ Green (RAG) System for Classifying Medicines in Sunderland Joint Formulary
- MISC5 NECS Useful Prescribing Information: A Guide For Prescribers
- MISC6 Patient Specific Directions
- MISC7 Procedure to Add Medicines, which may be Prescribed Elsewhere, to a Patient’s Record For Information
- MISC8 NECS Guideline for the Covert Administration of Medicines
- MISC9 Quick Guide: Covert Administration of Medications
- MISC10 NECS Individual Funding Request (IFR) Rapid Processing System
- MISC11 Quick Guide: Drug Monitoring Recommendations
- MISC12 NHS England Guidance for GP Practice Cold Chain
- MISC13 Procedure for Homely Remedies in Care homes